Retraction notice to "Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: Synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats" [Bioorg. Med. Chem. 17 (2007) 15 (2007) 4903-4909] (DOI:10.1016/j.bmc.2007.04.045);Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with l-tryptophan: Synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats

Bioorganic and Medicinal Chemistry

Volumn 15, Issue 14, 2007, Pages 4903-4909

  Dhaneshwar, Suneela S ^a   Gairola, Neha ^a   Kandpal, Mini ^a   Vadnerkar, Gaurav ^a   Bhatt, Lokesh ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

5 Aminosalicylic acid; Colon specific delivery; Inflammatory bowel disease; l Tryptophan; Mutual azo prodrug

Indexed keywords

ANTIULCER AGENT; AZO COMPOUND; BUFFER; GASTROINTESTINAL AGENT; HYDROCHLORIC ACID; MESALAZINE; MESALAZINE TRYPTOPHAN CONJUGATE; PHOSPHATE; SALAZOSULFAPYRIDINE; SALICYLIC ACID; TRINITROBENZENESULFONIC ACID; TRYPTOPHAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; COLD STRESS; COLITIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG HALF LIFE; DRUG RELEASE; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; INFRARED SPECTROSCOPY; KINETICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH; RAT; RAT STRAIN;

RATTUS;

EID: 34249735819     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2007.04.072     Document Type: Erratum

References (21)

1. Meyers D., and Sachar D.B. In: Kersnar J.B., and Shorter R.G. (Eds). Medical Therapy of Inflammatory Bowel Disease (1995), Williams and Wilkins, Baltimore 695-714
2. Bonner G.F. South Med. J. 89 (1996) 556
3. Brzezinski A., Rankin G.B., Seidner D.L., and Lshner B.A. Clev. Clin. J. Med. 62 (1995) 317
4. Bonner G.B., and Ruderman W.B. Inflammopharmacology (1993), Kluwer Academic, Norwell-Mass 247-262
5. Chourasia M.K., and Jain S.K. J. Pharm. Sci. 6 (2003) 33
6. Sands B.E. Gastroenterology 118 (2000) S68
7. Sutherland L.R., Rothy D.E., and Beck P.L. Inflam. Bowel Dis. 3 (1997) 65
8. Mahmud N., Kamm M.A., and Dupas J.L. Gut 49 (2001) 552
9. Rao S.S.C., Read N.W., and Holdsworth C.D. Gut 28 (1987) 1474
10. Takagi, K., Okabe, S.U.S. Patent No., US 3, 1976, 988466.
11. Dhaneshwar S., and Chaturvedi S.C. Indian Drugs 31 (1994) 374
12. Furniss B.S., Hannaford A.J., Smith P.W.G., and Tatchell A.R. Vogel's Textbook of Practical ORganic Chemistry. 5th ed. (2004), The English Language Bookman, London 835-836
13. March J. Advanced Organic Chemistry-Reactions, Mechanisms and Structure. 4th ed. (1992), Wiley Eastern Ltd, Singapore 635-636
14. Rubinstein A., Nakar D., and Sintov A. Pharm. Res. 9 (1992) 276
15. Rainsford K.D. Proc. British Pharmacol. Soc. (1980) 226
16. Rainsford K.D. Agents Actions 5 (1975) 553
17. Morris G.P., Beck P.L., Herridge M.S., and Drew W.T. Gastroenterology 96 (1989) 795
18. Zingarelli B., Squadrito F., Graziani P., Camerini R., and Caputi A.P. Agents Actions 39 (1993) 150
19. Li T. World J. Gasteroenterol. 9 (2003) 1028
20. Yamada T., Marshall S., Specian R.D., and Grisham M.B. Gastroenterology 102 (1992) 1524
21. Hartmann G., Bidlingamaier C., Seigmund B., Albrich S., Schulze J., Tschoep K., Eigler A., Lehr H.A., and Endres S. J. Pharmacol. Exp. Ther. 292 (2000) 22